Par Drugs and Chemicals Limited (NSE:PAR)
98.77
+1.87 (1.93%)
At close: Feb 16, 2026
Par Drugs and Chemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 275.77 | 366.54 | 222.43 | 162.06 | 211.64 |
Cash & Short-Term Investments | 338.56 | 275.77 | 366.54 | 222.43 | 162.06 | 211.64 |
Cash Growth | 80.25% | -24.76% | 64.79% | 37.25% | -23.42% | 186.81% |
Accounts Receivable | - | 167.14 | 137.14 | 169.69 | 184.67 | 124.51 |
Other Receivables | - | - | - | - | 0.74 | 1.37 |
Receivables | - | 168.13 | 138.09 | 170.45 | 185.91 | 126.19 |
Inventory | - | 61.94 | 44.21 | 59.68 | 54.98 | 38.9 |
Prepaid Expenses | - | 0.33 | 0.37 | 0.43 | 0.48 | 0.55 |
Other Current Assets | - | 42.44 | 47.02 | 41.38 | 32.2 | 34.57 |
Total Current Assets | - | 548.61 | 596.24 | 494.37 | 435.64 | 411.86 |
Property, Plant & Equipment | - | 389.15 | 413.35 | 386.95 | 343.51 | 344.3 |
Long-Term Investments | - | 250.7 | 0.12 | 0.1 | 0.1 | 0.1 |
Other Long-Term Assets | - | 5.44 | 6.41 | 7.26 | 7.65 | 7.58 |
Total Assets | - | 1,194 | 1,016 | 888.68 | 786.9 | 763.84 |
Accounts Payable | - | 108.91 | 53.56 | 80.92 | 106.62 | 67.18 |
Accrued Expenses | - | 6.28 | 21 | 20.4 | 8.41 | 19.71 |
Short-Term Debt | - | - | - | - | - | 32.48 |
Current Portion of Long-Term Debt | - | - | - | - | - | 6.82 |
Current Income Taxes Payable | - | 45.25 | 49.76 | 37.95 | 33.45 | 33.61 |
Current Unearned Revenue | - | 5.23 | 0.05 | 0.62 | 0.09 | - |
Other Current Liabilities | - | 0.02 | 0.02 | 0 | 0 | 0.01 |
Total Current Liabilities | - | 165.69 | 124.39 | 139.89 | 148.57 | 159.79 |
Long-Term Debt | - | - | - | - | - | 43.92 |
Pension & Post-Retirement Benefits | - | 2.67 | - | 1.4 | 4.06 | 3.94 |
Long-Term Deferred Tax Liabilities | - | 35.8 | 35.4 | 35 | 35.5 | 34.05 |
Other Long-Term Liabilities | - | 0 | - | - | - | - |
Total Liabilities | - | 204.15 | 159.79 | 176.3 | 188.13 | 241.7 |
Common Stock | - | 123.05 | 123.05 | 123.05 | 123.05 | 61.52 |
Additional Paid-In Capital | - | 106.73 | 106.73 | 106.73 | 106.73 | 168.25 |
Retained Earnings | - | 759.29 | 625.86 | 481.93 | 368.31 | 291.69 |
Comprehensive Income & Other | - | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 |
Total Common Equity | 1,064 | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 |
Shareholders' Equity | 1,064 | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 |
Total Liabilities & Equity | - | 1,194 | 1,016 | 888.68 | 786.9 | 763.84 |
Total Debt | - | - | - | - | - | 83.21 |
Net Cash (Debt) | 338.56 | 275.77 | 366.54 | 222.43 | 162.06 | 128.43 |
Net Cash Growth | 80.25% | -24.76% | 64.79% | 37.25% | 26.19% | 839.12% |
Net Cash Per Share | 27.52 | 22.41 | 29.79 | 18.08 | 13.17 | 10.44 |
Filing Date Shares Outstanding | 12.3 | 12.3 | 12.3 | 12.3 | 12.3 | 12.3 |
Total Common Shares Outstanding | 12.3 | 12.3 | 12.3 | 12.3 | 12.3 | 12.3 |
Working Capital | - | 382.93 | 471.84 | 354.48 | 287.07 | 252.06 |
Book Value Per Share | 86.60 | 80.44 | 69.59 | 57.90 | 48.66 | 42.43 |
Tangible Book Value | 1,064 | 989.75 | 856.32 | 712.38 | 598.77 | 522.15 |
Tangible Book Value Per Share | 86.60 | 80.44 | 69.59 | 57.90 | 48.66 | 42.43 |
Land | - | 31.48 | 31.48 | 6.21 | 3.32 | 3.32 |
Buildings | - | 202.81 | 198.21 | 183.18 | 152.36 | 138.89 |
Machinery | - | 463.15 | 459.94 | 443.59 | 413.09 | 355.88 |
Construction In Progress | - | - | 0.25 | 2.45 | 2.48 | 45.22 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.